HB Wealth Management LLC Purchases 177 Shares of CME Group Inc. $CME

HB Wealth Management LLC raised its position in shares of CME Group Inc. (NASDAQ:CME) by 2.3% in the second quarter, HoldingsChannel reports. The firm owned 7,913 shares of the financial services provider’s stock after buying an additional 177 shares during the quarter. HB Wealth Management LLC’s holdings in CME Group were worth $2,181,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also made changes to their positions in the company. Vanguard Group Inc. grew its stake in shares of CME Group by 1.2% during the 1st quarter. Vanguard Group Inc. now owns 34,643,827 shares of the financial services provider’s stock valued at $9,190,661,000 after purchasing an additional 400,737 shares during the period. Raymond James Financial Inc. grew its stake in shares of CME Group by 9.7% during the 1st quarter. Raymond James Financial Inc. now owns 4,113,991 shares of the financial services provider’s stock valued at $1,091,401,000 after purchasing an additional 363,130 shares during the period. Massachusetts Financial Services Co. MA grew its stake in shares of CME Group by 29.9% during the 1st quarter. Massachusetts Financial Services Co. MA now owns 2,818,590 shares of the financial services provider’s stock valued at $747,744,000 after purchasing an additional 648,591 shares during the period. AQR Capital Management LLC grew its stake in shares of CME Group by 10.3% during the 1st quarter. AQR Capital Management LLC now owns 2,783,759 shares of the financial services provider’s stock valued at $735,539,000 after purchasing an additional 260,065 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of CME Group by 11.9% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,727,809 shares of the financial services provider’s stock valued at $723,660,000 after purchasing an additional 290,147 shares during the period. 87.75% of the stock is currently owned by institutional investors.

CME Group Stock Down 1.6%

NASDAQ CME opened at $265.84 on Thursday. The stock’s 50 day moving average is $270.51 and its 200 day moving average is $271.09. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 12 month low of $213.94 and a 12 month high of $290.79. The stock has a market cap of $95.80 billion, a PE ratio of 25.73, a P/E/G ratio of 4.90 and a beta of 0.41.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping analysts’ consensus estimates of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The company had revenue of $1.69 billion for the quarter, compared to analysts’ expectations of $1.68 billion. During the same period in the previous year, the firm earned $2.56 EPS. The firm’s revenue was up 10.4% compared to the same quarter last year. Research analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were issued a $1.25 dividend. The ex-dividend date of this dividend was Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. CME Group’s payout ratio is currently 48.40%.

Wall Street Analysts Forecast Growth

CME has been the subject of a number of recent research reports. UBS Group cut their price objective on CME Group from $305.00 to $285.00 and set a “neutral” rating for the company in a research note on Monday, September 8th. Barclays set a $298.00 price objective on CME Group and gave the company an “equal weight” rating in a research note on Thursday, July 24th. Wall Street Zen downgraded CME Group from a “hold” rating to a “sell” rating in a research note on Sunday, July 13th. Citigroup upgraded CME Group from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $275.00 to $300.00 in a research note on Thursday, September 25th. Finally, Piper Sandler boosted their price objective on CME Group from $283.00 to $296.00 and gave the company an “overweight” rating in a research note on Tuesday, July 15th. Five equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $268.71.

Insiders Place Their Bets

In other news, General Counsel Jonathan L. Marcus sold 392 shares of the stock in a transaction that occurred on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total transaction of $102,704.00. Following the completion of the transaction, the general counsel directly owned 7,851 shares in the company, valued at approximately $2,056,962. This represents a 4.76% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Timothy Francis Mccourt sold 379 shares of the stock in a transaction that occurred on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total value of $98,475.57. Following the transaction, the insider owned 9,508 shares of the company’s stock, valued at $2,470,463.64. This represents a 3.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 13,043 shares of company stock valued at $3,527,956 in the last 90 days. 0.30% of the stock is currently owned by company insiders.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.